Dr. Lioudis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
750 EAST ADAMS STREET
Syracuse, NY 13210Phone+1 315-464-5290Fax+1 315-464-5295
Summary
- Dr. Michael Lioudis is the division chief of nephrology at Upstate Medical University in Syracuse, NY and holds the Edward T. Schroeder, MD endowed chair in nephrology and hypertension research. He is affiliated with multiple hospitals in the area, including Upstate Community Hospital and the VA Hospital. He received his medical degree from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and has been in practice for 21 years. He specializes in acute renal failure, hypertension, autosomal dominant polycystic kidney disease, renovascular medicine, glomerular disease, and dialysis.
Education & Training
- University of Pennsylvania Health SystemFellowship, Nephrology, 2007 - 2009
- Penn State Milton S Hershey Medical CenterChief Residency, Internal Medicine/Pediatrics, 2006 - 2007
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine/Pediatrics, 2004 - 2006
- Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine/Pediatrics, 2003 - 2004
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1999
Certifications & Licensure
- NY State Medical License 2021 - 2026
- OH State Medical License 2009 - 2026
- PA State Medical License 2004 - 2010
- MI State Medical License 2003 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis.Michael Lioudis, Xiaolei Zhou, Eric Davenport, Sasikiran Nunna, Holly B Krasa
BMC Nephrology. 2023-06-22 - 3 citationsRenal Genetics Clinic: 3-Year Experience in the Cleveland Clinic.Xin Yee Tan, Chloe Borden, Mary-Beth Roberts, Sarah Mazzola, Queenie K-G Tan
Kidney Medicine. 2023-02-01 - 1 citationsProlonged Blood Storage and Risk of Posttransfusion Acute Kidney Injury.Janet Adegboye, Suneeti Sapatnekar, Edward J. Mascha, Karan Shah, Michael Lioudis
Anesthesiology. 2021-11-18
Press Mentions
- NKF Roundup: Latest Data on Tolvaptan, Terlipressin, and LumasiranApril 17th, 2023
- The Close Link Between Your Heart Health and Kidney HealthFebruary 13th, 2020
- Cleveland Clinic Receives $2 Million Gift for Nephrology, Hypertension ResearchMarch 15th, 2016
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: